KSMC Laboratories: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KSMC Laboratories
Largest movements
- Receivables within one year -€472,786
down €472,786 (-63.3%), from €746,794 to €274,007
of which Trade receivables: -€426,779
- Cash +€13,829
up €13,829 (+64.9%), from €21,324 to €35,153
mainly Receivables within one year (+€472,786) and Other debts (+€39,243)
- Stocks and contracts +€11,236
up €11,236 (+7.5%), from €149,315 to €160,551
- Trade debts -€324,829
down €324,829 (-68.2%), from €476,632 to €151,802
- Reserves +€174,830
up €174,830 (+3,497%), from €5,000 to €179,830
of which Distributable reserves: +€174,830
- Profit (loss) carried forward -€139,124
no longer reported in 2025 (was €139,124)
- Advances received -€103,703
no longer reported in 2025 (was €103,703)
- Current portion of long-term debt -€44,133
no longer reported in 2025 (was €44,133)
- Gross operating margin -€41,415
down €41,415 (-54.5%), from €76,027 to €34,612
- Taxes -€16,681
down €16,681, from €2,897 to -€13,784
- Financial charges -€6,982
down €6,982 (-43.8%), from €15,926 to €8,944
- Staff costs -€3,698
no longer reported in 2025 (was €3,698)
- Depreciation +€2,222
up €2,222 (+601%), from €370 to €2,592
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €936,181 | €483,083 | -€453,099 | -48.4% |
| Fixed assets | 21/28 | €13,135 | €11,148 | -€1,987 | -15.1% |
| Tangible fixed assets | 22/27 | €11,340 | €9,653 | -€1,687 | -14.9% |
| Furniture and vehicles | 24 | €11,340 | €9,653 | -€1,687 | -14.9% |
| Financial fixed assets | 28 | €1,795 | €1,495 | -€300 | -16.7% |
| Current assets | 29/58 | €923,046 | €471,935 | -€451,111 | -48.9% |
| Stocks and contracts in progress | 3 | €149,315 | €160,551 | +€11,236 | +7.5% |
| Stocks | 30/36 | €149,315 | €160,551 | +€11,236 | +7.5% |
| Amounts receivable within one year | 40/41 | €746,794 | €274,007 | -€472,786 | -63.3% |
| Trade receivables | 40 | €689,764 | €262,985 | -€426,779 | -61.9% |
| Other amounts receivable | 41 | €57,030 | €11,023 | -€46,007 | -80.7% |
| Current investments | 50/53 | €2,500 | - | -€2,500 | |
| Cash at bank and in hand | 54/58 | €21,324 | €35,153 | +€13,829 | +64.9% |
| Deferred charges and accrued income | 490/1 | €3,113 | €2,224 | -€890 | -28.6% |
| Total equity and liabilities | 10/49 | €936,181 | €483,083 | -€453,099 | -48.4% |
| Equity | 10/15 | €194,124 | €229,830 | +€35,706 | +18.4% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Capital | 10 | €50,000 | - | -€50,000 | |
| Issued capital | 100 | €50,000 | - | -€50,000 | |
| Reserves | 13 | €5,000 | €179,830 | +€174,830 | +3,497% |
| Non-distributable reserves | 130/1 | €5,000 | €5,000 | = | 0.0% |
| Legal reserve | 130 | €5,000 | - | -€5,000 | |
| Reserves not available under the articles | 1311 | - | €5,000 | +€5,000 | |
| Distributable reserves | 133 | - | €174,830 | +€174,830 | |
| Profit (loss) carried forward | 14 | €139,124 | - | -€139,124 | |
| Amounts payable | 17/49 | €742,057 | €253,253 | -€488,804 | -65.9% |
| Amounts payable within one year | 42/48 | €742,057 | €253,253 | -€488,804 | -65.9% |
| Current portion of amounts payable after more than one year | 42 | €44,133 | - | -€44,133 | |
| Financial debts | 43 | €33,781 | - | -€33,781 | |
| Credit institutions | 430/8 | €33,781 | - | -€33,781 | |
| Trade debts | 44 | €476,632 | €151,802 | -€324,829 | -68.2% |
| Suppliers | 440/4 | €476,632 | €151,802 | -€324,829 | -68.2% |
| Advances received on contracts in progress | 46 | €103,703 | - | -€103,703 | |
| Taxes, remuneration and social security | 45 | €33,808 | €12,207 | -€21,601 | -63.9% |
| Taxes | 450/3 | €31,950 | €8,841 | -€23,108 | -72.3% |
| Remuneration and social security | 454/9 | €1,858 | €3,366 | +€1,507 | +81.1% |
| Other amounts payable | 47/48 | €50,000 | €89,243 | +€39,243 | +78.5% |
| Remuneration, social security and pensions | 62 | €3,698 | - | -€3,698 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €370 | €2,592 | +€2,222 | +601% |
| Other operating charges | 640/8 | €1,995 | €1,160 | -€835 | -41.8% |
| Non-recurring operating charges | 66A | €36,988 | - | -€36,988 | |
| Gross operating margin | 9900 | €76,027 | €34,612 | -€41,415 | -54.5% |
| Operating profit (loss) | 9901 | €32,975 | €30,860 | -€2,116 | -6.4% |
| Financial income | 75/76B | €8 | €7 | -€1 | -15.2% |
| Recurring financial income | 75 | €8 | €7 | -€1 | -15.2% |
| Financial charges | 65/66B | €15,926 | €8,944 | -€6,982 | -43.8% |
| Recurring financial charges | 65 | €15,926 | €8,944 | -€6,982 | -43.8% |
| Profit (loss) for the period before taxes | 9903 | €17,057 | €21,922 | +€4,865 | +28.5% |
| Income taxes | 67/77 | €2,897 | -€13,784 | -€16,681 | |
| Profit (loss) for the period | 9904 | €14,160 | €35,706 | +€21,546 | +152% |
| Profit (loss) for the period to be appropriated | 9905 | €14,160 | €35,706 | +€21,546 | +152% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.